British pharmaceutical giant GSK has struck a significant deal worth up to $1.15 billion to acquire IDRx, a Massachusetts-based biopharmaceutical company, strengthening its position in the oncology sector. The FTSE
All posts tagged in GSK acquisition
1Article
- Home
- GSK acquisition
Recent Posts
- Cinema Operators Pursue Premium Strategy as UK Box Office Targets Pre Pandemic Recovery
- British Mobile Tech Unicorn Nothing Remains Non Committal on London IPO Plans
- Boxing Day Sales Expected to Fall by 1 Billion Pounds Amid Economic Pressures
- Hedge Funds Position Against UK Retail Stocks Ahead of Christmas Trading Results
- UK Set to Become Fifth Largest Global Economy by 2040
- UK Living Standards Projected to Fall Behind Malta by 2035
- Rising Artificial Intelligence Infrastructure Costs Drive Consumer Price Increases Across Multiple Sectors
- UK Live Music Industry Faces Existential Threat as Grassroots Venues Struggle Beneath Supertour Boom
- US Economy Expands 43 Per Cent in Q3 2025 Outpacing G7 Peers
- Gold and Silver Rally to Unprecedented Levels as Market Dynamics Shift
- South Korea Transforms Gaming Industry Into Major Economic Export Powerhouse
- UK Electric Car Charger Rollout Slows Amid Policy Uncertainty and Investment Concerns in 2025
- UK Government Deploys Over One Million Pounds on Influencer Marketing Strategy Since 2024
- Poundland Draws Emergency Overdraft Amid Deepening Retail Crisis
- Petrofac North Sea Operations Acquired by CBI Securing 3000 UK Energy Jobs
- BP Divests Castrol Majority Stake in Strategic Refocus 2025
- The Second China Shock and the Growing Threat to European Industry
- Four day week warning issued to English local councils by government
- Ryanair fined €256m euros by Italian regulator for blocking online travel agents
- Scottish whisky sector faces supply glut amid sliding sales and tariffs
- European Electric Car Sales Surge as Tesla Loses Ground in Key Markets
- Glastonbury Profits Surge as Iconic Festival Fuels Record Charitable Giving
- Videndum shares plunge as refinancing plan dilutes investor stakes
- Novo Nordisk gains edge as US approves weight loss pill
- Bet365 Chief Denise Coates Earns £280 Million Despite Decline In Profits
- Private equity duo receive lengthy bans over banking system exploitation
- Freshfields boosts Gen Z resilience with new city law career training
- US economy driven by AI and data centre investment surprises markets with strong growth
- Labour Government Backs Down on Inheritance Tax for Family Farmers After Rural Backlash
- Billionaire Donor Alan Howard Leaves Britain for Switzerland Amid Labour Tax Hike
